{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T07:06:23Z","timestamp":1790924783223,"version":"4.1.0"},"reference-count":48,"publisher":"American Society for Microbiology","issue":"8","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Clin Microbiol"],"published-print":{"date-parts":[[2005,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>To evaluate whether a new enzyme immunoassay developed for the simultaneous detection of hepatitis C virus (HCV) core antigen (Ag) and anti-HCV antibodies (anti-HCV Ab) (Monolisa HCV Ag\/Ab ULTRA; Bio-Rad) could improve the early detection of HCV infection, we compared its sensitivity to that of anti-HCV, HCV core Ag, and HCV RNA assays. The populations studied included 12 blood donor samples positive for HCV RNA and HCV core Ag but negative for anti-HCV antibodies and 23 hemodialysis patients who developed anti-HCV Ab (seroconversion) during the follow-up. From these 23 individuals, 83 samples sequentially collected prior to seroconversion and 108 samples collected after seroconversion were tested. Six of 12 blood donations were positive by the HCV Ag\/Ab assay. In the hemodialysis cohort, the 24 HCV RNA-negative samples were negative by the HCV Ag\/Ab assay and 23 of the 59 HCV RNA-positive samples (39%) were positive. The HCV Ag\/Ab assay detected HCV infection on average 21.6 days before the most sensitive antibody assay. The HCV Ag\/Ab assay did not detect HCV infection as early as the HCV RNA assay (mean delay, 30.3 days) or HCV Ag assay (mean delays, 27.9, and 16.3 days by the HCV core Ag quantification assay and the HCV Ag blood screening assay, respectively). This new assay provides a notable improvement for the early detection of HCV infection during the so-called window period compared with anti-HCV Ab assays and could be a useful alternative to HCV RNA detection or HCV core Ag assays for diagnosis or blood screening when nucleic acid technologies or HCV core Ag detection are not implemented.<\/jats:p>","DOI":"10.1128\/jcm.43.8.3877-3883.2005","type":"journal-article","created":{"date-parts":[[2005,8,4]],"date-time":"2005-08-04T22:25:57Z","timestamp":1123194357000},"page":"3877-3883","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":86,"title":["Simultaneous Detection of Hepatitis C Virus (HCV) Core Antigen and Anti-HCV Antibodies Improves the Early Detection of HCV Infection"],"prefix":"10.1128","volume":"43","author":[{"given":"Syria","family":"Laperche","sequence":"first","affiliation":[{"name":"National Reference Center for Hepatitis B and C in Transfusion, Institut National de la Transfusion Sanguine, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Le Marrec","sequence":"additional","affiliation":[{"name":"National Reference Center for Hepatitis B and C in Transfusion, Institut National de la Transfusion Sanguine, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Girault","sequence":"additional","affiliation":[{"name":"National Reference Center for Hepatitis B and C in Transfusion, Institut National de la Transfusion Sanguine, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franc\u0327oise","family":"Bouchardeau","sequence":"additional","affiliation":[{"name":"National Reference Center for Hepatitis B and C in Transfusion, Institut National de la Transfusion Sanguine, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabelle","family":"Servant-Delmas","sequence":"additional","affiliation":[{"name":"National Reference Center for Hepatitis B and C in Transfusion, Institut National de la Transfusion Sanguine, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miche\u0300le","family":"Maniez-Montreuil","sequence":"additional","affiliation":[{"name":"Etablissement Franc\u0327ais du Sang Nord-de-France, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Gallian","sequence":"additional","affiliation":[{"name":"Etablissement Franc\u0327ais du Sang Alpes-Me\u0301diterrane\u0301e, Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Levayer","sequence":"additional","affiliation":[{"name":"Etablissement Franc\u0327ais du Sang Pyre\u0301ne\u0301es-Me\u0301diterrane\u0301e, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Morel","sequence":"additional","affiliation":[{"name":"Etablissement Franc\u0327ais du Sang Bourgogne Franche-Comte\u0301, Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Simon","sequence":"additional","affiliation":[{"name":"Unite\u0301 d'He\u0301modialyse Association pour l'Utilisation du Rein Artificiel, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0042-9007.2004.00513.x"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1246-7820(03)00049-1"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1995.tb02538.x"},{"key":"e_1_3_2_5_2","first-page":"211","volume":"36","year":"2002","unstructured":"Bouvier-Alias, M., K. Patel, H. Dahari, S. Beaucourt, P. Larderie, L. Blatt, C. Hezode, G. Picchio, D. Dhumeaux, A. U. Neumann, J. G. McHutchison, and J. M. Pawlotsky. 2002. Clinical utility of total HCV core antigen quantification: a new indirect marker of HCV replication. Hepatology36:211-218.","journal-title":"Hepatology"},{"key":"e_1_3_2_6_2","first-page":"33","year":"2001","unstructured":"Busch, M. 2001. Closing the windows on viral transmission by blood transfusion, p. 33-54. In S. L. Stramer (ed.), Blood safety in the new millenium. American Association of Blood Banks, Bethesda, Md.","journal-title":"Blood safety in the new millenium"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2003.00524.x"},{"key":"e_1_3_2_8_2","first-page":"527","volume":"40","year":"2004","unstructured":"Buti, M., C. Mendez, M. Schaper, S. Sauleda, A. Valdes, F. Rodriguez-Frias, R. Jardi, and R. Esteban. 2004. Hepatitis C virus core antigen as a predictor of non-response in genotype 1 chronic hepatitis C patients treated with peginterferon alpha-2b plus ribavirin. J. Hepatol.40:527-532.","journal-title":"J. Hepatol."},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3148.2003.00452.x"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)17315-7"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2003.00328.x"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2000.40101198.x"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199611213352115"},{"key":"e_1_3_2_14_2","first-page":"74","volume":"133","year":"2000","unstructured":"Durand, F., A. Beauplet, and P. Marcellin. 2000. Evidence of hepatitis C virus viremia without detectable antibody to hepatitis C virus in a blood donor. Ann. Intern. Med.133:74-75.","journal-title":"Ann. Intern. Med."},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2003.00420.x"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1423-0410.2003.00311.x"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2002.00200.x"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2003.00392.x"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.40.5.1761-1766.2002"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.42.9.4054-4059.2004"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2496467"},{"key":"e_1_3_2_22_2","first-page":"3","volume":"10","year":"2005","unstructured":"Laperche, S. 2005. Blood safety and nucleic acid testing in Europe. Euro Surveill. 10:3-4.","journal-title":"Blood safety and nucleic acid testing in Europe"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0042-9007.2004.00414.x"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2003.00430.x"},{"key":"e_1_3_2_25_2","first-page":"227","volume":"2","year":"1998","unstructured":"Lefrere, J. 1998. S\u00e9curit\u00e9 virale et transplantation d'organes. Virologie2:227-232.","journal-title":"Virologie"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2004.03340.x"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviromet.2004.08.018"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1246-7820(00)80012-9"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0042-9007.2004.00379.x"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2893.2003.00430.x"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-0934(03)00215-5"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.42.4.1631-1636.2004"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2002.00166.x"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2003.00475.x"},{"key":"e_1_3_2_35_2","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1053\/jhep.2002.36815","volume":"36","year":"2002","unstructured":"Pawlotsky, J. M. 2002. Use and interpretation of virological tests for hepatitis C. Hepatology36:S65-S73.","journal-title":"Hepatology"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1423-0410.2000.7820080.x"},{"key":"e_1_3_2_37_2","first-page":"5","volume":"10","year":"2005","unstructured":"Pillonel, J., and S. Laperche. 2005. Trends in risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992 and 2003 and impact of nucleic acid testing (NAT). Euro Surveill.10:5-8.","journal-title":"Euro Surveill."},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2002.00155.x"},{"key":"e_1_3_2_39_2","first-page":"307","volume":"44","year":"2004","unstructured":"Raker, C. A., E. Tabor, A. Okayama, M. Y. Yu, M. Kohara, N. E. Mueller, H. Tsubouchi, and S. O. Stuver. 2004. HCV core antigen as an alternative to NAT to detect HCV viremia. Transfusion44:307-308.","journal-title":"Transfusion"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2002.00129.x"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1438.2002.00104.x"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2002.00204.x"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2003.00482.x"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08663-4"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa040085"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2000.9112"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2003.00521.x"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1080\/003655200451270"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2002.00173.x"}],"container-title":["Journal of Clinical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.43.8.3877-3883.2005","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.43.8.3877-3883.2005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T03:00:21Z","timestamp":1735873221000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JCM.43.8.3877-3883.2005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":48,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["10.1128\/JCM.43.8.3877-3883.2005"],"URL":"https:\/\/doi.org\/10.1128\/jcm.43.8.3877-3883.2005","relation":{},"ISSN":["0095-1137","1098-660X"],"issn-type":[{"value":"0095-1137","type":"print"},{"value":"1098-660X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8]]},"assertion":[{"value":"2004-12-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2005-05-09","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2005-08-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}